CTRI/2010/091/001138已完成3 期
A Control- Labeled, Prospective, Randomized, Parallel group, Multicentric, Phase III Clinical Trial to Evaluate Efficacy and Safety of Eperisone HCl SR Capsule compared with Eperisone HCl Tablet in patients suffering from Acute Musculoskeletal Spasm associated with Low Back Pain.
Inventia Health Care Pvt Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of either sex between 18 to 70 years of age.
- •Patients with confirmed diagnosis of Acute Musculoskeletal spasm with Low Back Pain due to:
- •Spondylosis deformans.
- •Prolapsed Intervertebral Disc (PID).
- •Muscle sprains with spasms.
- •Patients who are willing to take the medications as directed and willing to come for follow-ups.
- •Patients who are willing to comply with the protocol requirements.
- •Patients who are willing to give the written informed consent.
排除标准
- •Patients with other associated spasm conditions like traumatic pain with spasms, cervical spondylitis and pain and spasm associated with fractured bone.
- •Patients who had taken any form of skeletal muscle relaxant in the previous seven days
- •Patients with hypersensitivity to any of the ingredients of the study drug formulations.
- •Women of child bearing potential not following adequate contraceptive measures
- •Patients unwilling or unable to comply with the study procedures
- •Patients having a history of severe acute infection, major surgery, trauma, severe metabolic, endocrine or electrolyte disturbances and seizures in preceding eight weeks
- •Patients having severe hepatic insufficiency defined by an SGOT or SGPT value equal or higher than the three fold normal values of the respective laboratory reference value
- •Patients having any of the following disorders: Renal failure, Bulimia, Hypo and Hyperthyroidism, Nephrotic syndrome, Anorexia nervosa, biliary obstruction and severe cardiac dysfunction.
- •Patients having uncontrolled diabetes mellitus, or any other metabolic or endocrine disorder
- •Patients that have received treatment with any investigational drug in the preceding four weeks
研究者
相似试验
已完成
3 期
A Control- Labeled, Prospective, Randomized, Parallel Group, Multicentric, Phase III Clinical trial to evaluate Efficacy and Safety of a FDC of Lornoxicam 16mg SR + Thiocolchicoside 16mg SR Tablet OD Compared with FDC Lornoxicam 8mg + Thiocolchicoside 8mg Capsule BID in Patients Suffering from skeletal Muscular spasm of any etiology.CTRI/2011/091/000010Alembic Ltd200
招募中
3 期
A Clinical trial of Fixed Dose Combination of Lornoxicam 16mg SR + Thiocolchicoside 16mg SR Tablet OD Compared with Thiocolchicoside 8mg Capsule BID in Patients Suffering pain associated with Skeletal Muscular Spasm of any etiology.CTRI/2012/02/002440Inventia Healthcare Pvt Ltd200
已完成
3 期
Controlled Labeled, Randomized Prospective, Multicentric Parallel Group, Phase-III Clinical Trial to Compare Efficacy and Safety for FDC of Eperisone150mg SR and Diclofenac 100mg SR capsule OD with Eperisone 50 mg EC Tablet T.I.D in Subjects suffering with Acute Musculoskeletal Spasm Associated With Low Backache.CTRI/2010/091/001154Inventia Health Care Pvt. Ltd.200
已完成
4 期
To assess safety, efficacy and tolerability of Formoterol Budesonide nebulised formulationin comparison with Formoterol Budesonide pressurized meter dose formulation inCOPD patientsCTRI/2012/11/003087Cipla Ltd112
尚未招募
Unknown
A Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Electroacupuncture and Its Cotreatment with Electronic Moxibustion for Dry eye syndromeKCT0009622aju Dongshin University Korean Medicine Hospital45
